secwatch.observer — SEC 8-K summary
======================================

Issuer:     QT IMAGING HOLDINGS, INC. (QTI)
CIK:        0001844505
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001193125-24-082707
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QT Imaging enters feasibility study agreement with Canon Medical Systems for ultrasound breast scanner evaluation
--------------------------------------------------------------------------------

- Canon will evaluate QT Scanner for business, technical, clinical value including quality validation, manufacturing, regulatory, market validation.
- Term runs from March 28, 2024 through end of December 2024 or until superseded by a definitive collaboration agreement.
- QTI grants Canon first priority in negotiations for collaborations (joint development, contract manufacturing, marketing) regarding ultrasound breast scanners.
- Each party bears own expenses; QTI provides existing technical materials with no significant additional cost.
- Canon has no right to reverse engineer; QTI retains all IP; liability limited to $1,000 (except for personal injury/property damage).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844505/000119312524082707/0001193125-24-082707-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844505/000119312524082707/d812253d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-082707

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer